Abstract

Hypoxia-inducible factors (HIFs) are heterodimeric transcription factors that can promote cancer growth. The development of small-molecule drugs that can inhibit the formation of the dimer is therefore a promising route to the treatment of cancer. Here, we focus on the relevant domain of the protein, the HIF2α PAS-B domain, which contains a preformed, buried cavity that binds artificial small-molecule ligands that allosterically perturb the formation of the HIF heterodimer. We examine how a representative ligand (THS-017) dissociates and re-enters the buried cavity using atomistic simulations. To enable these simulations, we applied the weighted ensemble path sampling strategy, which can generate continuous pathways with rigorous kinetics (i.e., rate constants) in orders of magnitude less computing time compared to standard simulations. Results reveal a diverse set of pathways for both the ligand unbinding and rebinding processes with estimated rate constants and methyl order parameters that are consistent with experiment.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call